ESR1 and EGFgenetic variation in relation to breast cancer risk and survival
Authors:
- Kristjana EinarsdóttirKEKristjana Einarsdóttir
- Hatef DarabiHDHatef Darabi
- Yi LiYLYi Li
- Yen Ling LowYLYen Ling Low
- Yu Qing LiYLYu Qing Li
- Carine BonnardCBCarine Bonnard
- Arvid SjölanderASArvid Sjölander
- Kamila CzeneKCKamila Czene
- Sara WedrénSWSara Wedrén
- Edison T LiuELEdison T Liu
- Per HallPHPer Hall
- Keith HumphreysKHKeith Humphreys
Open Access
- 14 February 2008
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 10 (1) , R15
Abstract
Introduction: Oestrogen exposure is a central factor in the development of breast cancer. Oestrogen receptor alpha (ESR1) is the main mediator of oestrogen effect in breast epithelia and has also been shown to be activated by epidermal growth factor (EGF). We sought to determine if common genetic variation in the ESR1 and EGF genes affects breast cancer risk, tumour characteristics or breast cancer survival. Methods: We genotyped 157 single nucleotide polymorphisms (SNPs) in ESR1 and 54 SNPs in EGF in 92 Swedish controls and selected haplotype tagging SNPs (tagSNPs) that could predict both single SNP and haplotype variation in the genes with an R2 of at least 0.8. The tagSNPs were genotyped in 1,590 breast cancer cases and 1,518 controls, and their association with breast cancer risk, tumour characteristics and survival were assessed using unconditional logistic regression models, Cox proportional hazard models and haplotype analysis. Results: The single tagSNP analysis did not reveal association evidence for breast cancer risk, tumour characteristics, or survival. A multi-locus analysis of five adjacent tagSNPs suggested a region in ESR1 (between rs3003925 and rs2144025) for association with breast cancer risk (p = 0.001), but the result did not withstand adjustment for multiple comparisons (p = 0.086). A similar region was also implicated by haplotype analyses, but its significance needs to be verified by follow-up analysis. Conclusion: Our results do not support a strong association between common variants in the ESR1 and EGF genes and breast cancer risk, tumour characteristics or survival.Keywords
This publication has 33 references indexed in Scilit:
- ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United StatesBreast Cancer Research and Treatment, 2006
- Genes, environment and the value of prospective cohort studiesNature Reviews Genetics, 2006
- Joint Effects of the CYP1A1 MspI, ERα PvuII, and ERα XbaI Polymorphisms on the Risk of Breast Cancer: Results from a Population-Based Case-Control Study in Shanghai, ChinaCancer Epidemiology, Biomarkers & Prevention, 2006
- The Estrogen Receptor α Gene and Breast Cancer Risk (The Netherlands)Cancer Causes & Control, 2005
- Obtaining Unbiased Estimates of Tagging SNP PerformanceAnnals of Human Genetics, 2005
- Association of estrogen receptor α polymorphisms with breast cancer risk in older Caucasian womenInternational Journal of Cancer, 2005
- Use of unphased multilocus genotype data in indirect association studiesGenetic Epidemiology, 2004
- Fine-Scale Mapping of Disease Genes with Multiple Mutations via Spatial Clustering TechniquesThe American Journal of Human Genetics, 2003
- Selection and Evaluation of Tagging SNPs in the Neuronal-Sodium-Channel Gene SCN1A: Implications for Linkage-Disequilibrium Gene MappingThe American Journal of Human Genetics, 2003
- The Structure of Haplotype Blocks in the Human GenomeScience, 2002